Revolutionary Polychromatic Photobiomodulation System The Hemealumen TS Polychromatic Device is a cutting-edge, minimally invasive photoluminescence blood treatment system designed to combat auto-immune, viral, bacterial, and fungal diseases. It is also effective for treating similar conditions in pets, including dogs and cats. This advanced device enhances patient outcomes by utilizing light-based therapy to stimulate the body's natural healing processes. Immediate Clinical Impact Immediate Impact: Complete resolution of dengue/zika in 48 hours. 55/55 malaria cases resolved in 2 days. Zero COVID-19 mortality with 7-day reduced hospital stays. Proven Safety: Over 80 years of clinical use with >95% success rates across 6,500+ patients. Zero adverse effects reported in 200+ peer-reviewed studies. Revolutionary Technology: Patented TRIVETTE™ design increases blood exposure time by 600% compared to traditional devices, delivering superior therapeutic outcomes through polychromatic wavelength integration. How Hemealumen TS Works: Advanced Polychromatic Precision Patented TRIVETTE™ Triple Quartz Tube Design The revolutionary triple-tube parallel arrangement extends blood exposure time by 600%, ensuring comprehensive pathogen inactivation and optimal cellular activation. This patented design represents the first significant advancement in UVBI technology. Targeted Pulsed Frequencies Proprietary frequency modulation similar to Rife technology ensures precise cellular targeting while maximizing therapeutic efficacy across multiple biological systems. Transform Patient Outcomes Six-Wavelength Polychromatic System UVC 253.7nm: Direct DNA/RNA damage to pathogens while preserving host cell integrity UVA: Enhanced immune cell activation and phagocytic capacity Blue 450nm: Vasodilation, reduced inflammatory markers, improved blood flow Green 525nm: Blood rheology optimization, decreased viscosity, enhanced electrophoretic mobility Amber 590nm: Nitric oxide production, mood enhancement, anti-depression effects Red 675nm: Primary enzyme support (SOD, Catalase), mitochondrial energy optimization Clinical Evidence: Transforming Medical Outcomes Viral Infections - Breakthrough Results Hepatitis C: 44.9% peak viral load reduction in FDA Phase II trial (p=0.0048) COVID-19: 7-day hospital stay reduction with zero mortality rates Dengue/Zika: Complete resolution within 48 hours (Costa Rica clinical study) Long COVID: Significant symptom improvement with declining D-dimer levels Bacterial Infections - Superior Efficacy Tuberculosis: 100% disease-free rate vs. 58.8% in control groups Sepsis: Historical 95%+ success rate across 6,500+ patients MRSA/Antibiotic-Resistant Strains: No reported resistance development Pneumonia: 24-76 hour symptom resolution Autoimmune and Inflammatory Conditions Rheumatoid Arthritis: 70-92% improvement rates Asthma: Significant improvement in steroid-resistant cases Multiple Sclerosis: 14/26 patients showed good clinical response Psoriasis: Marked improvement in concurrent treatment cases Cardiovascular Applications Peripheral Arterial Disease: 3x improvement in walking distance Thrombophlebitis: 24-48 hour clot resolution Enhanced oxygen utilization and delivery Significant blood viscosity reduction Engineering Excellence: Technical Specifications Advanced LED Array System 60 High-Power LEDs: Delivering precise wavelength targeting Wavelength Range: 253.7nm UVC to 675nm Red light Power Output: 60 watts across multiple visible wavelengths Treatment Duration: Optimized exposure protocols for maximum efficacy User Interface and Controls Touchscreen Interface: Intuitive operation for clinical staff Pre-programmed Protocols: Evidence-based treatment parameters Real-time Monitoring: Continuous treatment parameter display Safety Interlocks: Multiple fail-safe mechanisms Patented TRIVETTE™ Cuvette Design Triple quartz tube parallel arrangement 600% increased blood exposure time Comprehensive pathogen inactivation Optimal cellular activation Note: This device is intended for use by qualified healthcare practitioners. Consult with your healthcare provider to determine if photobiomodulation therapy is appropriate for your individual needs